Iris Pharma has expertise in all phases of clinical research – phases 1, 2a, 2b, 3, and post-approval phase 4 studies – and in medico-marketing surveys.
Distribution of the trials undertaken with Iris Pharma by clinical phase
We effectively manage clinical trials to obtain marketing approval by the relevant authority, such as the European Medicines Agency (EMA) or the United States Food and Drug Administration (FDA).
